Leukemia and Lymphoma Program News and Updates

1 - 10 of 30

AML Immunotherapy Trial Opens

Published on in CHOP News

CHOP has opened a phase 1 trial using CAR T for tough acute myeloid leukemia, hoping to replicate the therapy’s success for acute lymphoblastic leukemia.


Pages